Apparent diffusion coefficient from magnetic resonance imaging as a biomarker in oncology drug development
- 9 January 2012
- journal article
- research article
- Published by Elsevier BV in European Journal of Cancer
- Vol. 48 (4), 425-431
- https://doi.org/10.1016/j.ejca.2011.11.034
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot studyEuropean Radiology, 2010
- Studies of anomalous diffusion in the human brain using fractional order calculusMagnetic Resonance in Medicine, 2010
- Diffusion-weighted MR Imaging of the LiverRadiology, 2010
- Diffusion‐weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): A feasibility studyJournal of Magnetic Resonance Imaging, 2009
- Sensitivity of MR diffusion measurements to variations in intracellular structure: Effects of nuclear sizeMagnetic Resonance in Medicine, 2009
- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and RecommendationsNeoplasia, 2009
- Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liverJournal of Magnetic Resonance Imaging, 2008
- New Insights into Tumor Microstructure Using Temporal Diffusion SpectroscopyCancer Research, 2008
- Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging.Radiology, 1988
- Restricted Diffusion in Biophysical Systems: ExperimentBiophysical Journal, 1974